{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:15:07Z","timestamp":1788383707774,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007664","name":"Manpei Suzuki Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K18393"],"award-info":[{"award-number":["22K18393"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00755-4","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:04:50Z","timestamp":1740978290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metformin-regulated glucose flux from the circulation to the intestinal lumen"],"prefix":"10.1038","volume":"5","author":[{"given":"Kazuhiko","family":"Sakaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusei","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2623-5599","authenticated-orcid":false,"given":"Yasuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-6474","authenticated-orcid":false,"given":"Yuichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Aburaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4608-4652","authenticated-orcid":false,"given":"Yoshihiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2738","authenticated-orcid":false,"given":"Takeshi","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Komada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munenobu","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-4366","authenticated-orcid":false,"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"755_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u2013476 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","volume":"21","author":"L He","year":"2015","unstructured":"He, L. & Wondisford, F. E. Metformin action: concentrations matter. Cell Metab. 21, 159\u2013162 (2015).","journal-title":"Cell Metab."},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/00498259409043220","volume":"24","author":"C Wilcock","year":"1994","unstructured":"Wilcock, C. & Bailey, C. J. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24, 49\u201357 (1994).","journal-title":"Xenobiotica"},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"LJ McCreight","year":"2016","unstructured":"McCreight, L. J., Bailey, C. J. & Pearson, E. R. Metformin and the gastrointestinal tract. Diabetologia 59, 426\u2013435 (2016).","journal-title":"Diabetologia"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850\u2013858 (2017).","journal-title":"Nat. Med."},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24, 1919\u20131929 (2018).","journal-title":"Nat. Med."},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2020).","journal-title":"Nature"},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-0488","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse, J. B. et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39, 198\u2013205 (2016).","journal-title":"Diabetes Care"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier, E. et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur. J. Nucl. Med. Mol. Imaging 35, 95\u201399 (2008).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1476-5381.1994.tb13128.x","volume":"112","author":"CJ Bailey","year":"1994","unstructured":"Bailey, C. J., Mynett, K. J. & Page, T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br. J. Pharmacol. 112, 671\u2013675 (1994).","journal-title":"Br. J. Pharmacol."},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1042\/bj2620881","volume":"262","author":"L Penicaud","year":"1989","unstructured":"Penicaud, L., Hitier, Y., Ferre, P. & Girard, J. Hypoglycaemic effect of metformin in genetically obese (fa\/fa) rats results from an increased utilization of blood glucose by intestine. Biochem. J. 262, 881\u2013885 (1989).","journal-title":"Biochem. J."},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/ecco-jcc\/jjv207","volume":"10","author":"G Pellino","year":"2016","unstructured":"Pellino, G. et al. PET\/MR versus PET\/CT imaging: impact on the clinical management of small-bowel Crohn\u2019s disease. J. Crohns Colitis 10, 277\u2013285 (2016).","journal-title":"J. Crohns Colitis"},{"key":"755_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12350-015-0094-7","volume":"23","author":"PJ Slomka","year":"2016","unstructured":"Slomka, P. J., Pan, T. & Germano, G. Imaging moving heart structures with PET. J. Nucl. Cardiol. 23, 486\u2013490 (2016).","journal-title":"J. Nucl. Cardiol."},{"key":"755_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/dom.14262","volume":"23","author":"J Ito","year":"2021","unstructured":"Ito, J. et al. Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by (18) F-labelled fluorodeoxyglucose positron emission tomography-MRI. Diabetes Obes. Metab. 23, 692\u2013699 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc20-0093","volume":"43","author":"Y Morita","year":"2020","unstructured":"Morita, Y. et al. Enhanced release of glucose into the intraluminal space of the intestine associated with metformin treatment as revealed by [(18)F]Fluorodeoxyglucose PET-MRI. Diabetes Care 43, 1796\u20131802 (2020).","journal-title":"Diabetes Care"},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","volume":"360","author":"AM Cypess","year":"2009","unstructured":"Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509\u20131517 (2009).","journal-title":"N. Engl. J. Med."},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.2967\/jnumed.115.159715","volume":"56","author":"O Gheysens","year":"2015","unstructured":"Gheysens, O. et al. Quantification, variability, and reproducibility of basal skeletal muscle glucose uptake in healthy humans using 18F-FDG PET\/CT. J. Nucl. Med. 56, 1520\u20131526 (2015).","journal-title":"J. Nucl. Med."},{"key":"755_CR18","first-page":"1005","volume":"42","author":"I Yokoyama","year":"2001","unstructured":"Yokoyama, I. et al. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients. J. Nucl. Med. 42, 1005\u20131010 (2001).","journal-title":"J. Nucl. Med."},{"key":"755_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.mric.2013.05.002","volume":"21","author":"SA Anupindi","year":"2013","unstructured":"Anupindi, S. A., Terreblanche, O. & Courtier, J. Magnetic resonance enterography: inflammatory bowel disease and beyond. Magn. Reson. Imaging Clin. N. Am. 21, 731\u2013750 (2013).","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jchromb.2017.01.042","volume":"1048","author":"J Rokka","year":"2017","unstructured":"Rokka, J., Gronroos, T. J., Viljanen, T., Solin, O. & Haaparanta-Solin, M. HPLC and TLC methods for analysis of [(18)F]FDG and its metabolites from biological samples. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 1048, 140\u2013149 (2017).","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/jcbfm.1985.24","volume":"5","author":"M Reivich","year":"1985","unstructured":"Reivich, M. et al. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J. Cereb. Blood Flow Metab. 5, 179\u2013192 (1985).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"755_CR22","first-page":"94","volume":"48","author":"J Tokugawa","year":"2007","unstructured":"Tokugawa, J., Ravasi, L., Nakayama, T., Schmidt, K. C. & Sokoloff, L. Operational lumped constant for FDG in normal adult male rats. J. Nucl. Med. 48, 94\u201399 (2007).","journal-title":"J. Nucl. Med."},{"key":"755_CR23","first-page":"1157","volume":"43","author":"MM Graham","year":"2002","unstructured":"Graham, M. M. et al. The FDG lumped constant in normal human brain. J. Nucl. Med. 43, 1157\u20131166 (2002).","journal-title":"J. Nucl. Med."},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.gastro.2006.12.040","volume":"132","author":"P Iozzo","year":"2007","unstructured":"Iozzo, P. et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology 132, 531\u2013542 (2007).","journal-title":"Gastroenterology"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s001250100026","volume":"44","author":"KA Virtanen","year":"2001","unstructured":"Virtanen, K. A. et al. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis. Diabetologia 44, 2171\u20132179 (2001).","journal-title":"Diabetologia"},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"E1122","DOI":"10.1152\/ajpendo.2000.279.5.E1122","volume":"279","author":"P Peltoniemi","year":"2000","unstructured":"Peltoniemi, P. et al. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am. J. Physiol. Endocrinol. Metab. 279, E1122\u2013E1130 (2000).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1071-3581(97)90061-1","volume":"4","author":"HE Botker","year":"1997","unstructured":"Botker, H. E. et al. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose. J. Nucl. Cardiol. 4, 125\u2013132 (1997).","journal-title":"J. Nucl. Cardiol."},{"key":"755_CR28","first-page":"833","volume":"18","author":"R Ogawa","year":"1970","unstructured":"Ogawa, R., Fujita, T. & Fukuda, Y. Blood volume studies in healthy Japanese adults (Jpn). Respir Circ 18, 833\u2013838 (1970).","journal-title":"Respir Circ"},{"key":"755_CR29","first-page":"72","volume":"26","author":"HB Lee","year":"1985","unstructured":"Lee, H. B. & Blaufox, M. D. Blood volume in the rat. J. Nucl. Med. 26, 72\u201376 (1985).","journal-title":"J. Nucl. Med."},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/jssc.201101121","volume":"35","author":"R Garcia-Villalba","year":"2012","unstructured":"Garcia-Villalba, R. et al. Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples. J Sep Sci 35, 1906\u20131913 (2012).","journal-title":"J Sep Sci"},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"11997","DOI":"10.1021\/acs.jafc.0c04723","volume":"68","author":"T Fushimi","year":"2020","unstructured":"Fushimi, T. et al. Dynamic metabolome analysis reveals the metabolic fate of medium-chain fatty acids in AML12 cells. J. Agric. Food Chem. 68, 11997\u201312010 (2020).","journal-title":"J. Agric. Food Chem."},{"key":"755_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13340-021-00545-y","volume":"13","author":"H Tsuchida","year":"2022","unstructured":"Tsuchida, H., Morita, Y., Nogami, M. & Ogawa, W. Metformin action in the gut-insight provided by [(18)F]FDG PET imaging. Diabetol Int 13, 35\u201340 (2022).","journal-title":"Diabetol Int"},{"key":"755_CR33","first-page":"245","volume":"39","author":"A Waki","year":"1998","unstructured":"Waki, A. et al. Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog. J. Nucl. Med. 39, 245\u2013250 (1998).","journal-title":"J. Nucl. Med."},{"key":"755_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.diabres.2017.07.015","volume":"131","author":"JP Koffert","year":"2017","unstructured":"Koffert, J. P. et al. Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial. Diabetes Res. Clin. Pract. 131, 208\u2013216 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"755_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnumed.112.106666","volume":"54","author":"M Massollo","year":"2013","unstructured":"Massollo, M. et al. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J. Nucl. Med. 54, 259\u2013266 (2013).","journal-title":"J. Nucl. Med."},{"key":"755_CR36","first-page":"594","volume":"30","author":"L Bielicki","year":"1980","unstructured":"Bielicki, L., Krieglstein, J. & Wever, K. Key enzymes of glycolysis in brain as influenced by thiopental. Arzneimittelforschung 30, 594\u2013597 (1980).","journal-title":"Arzneimittelforschung"},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1213\/01.ane.0000297299.91527.74","volume":"106","author":"CJ Zuurbier","year":"2008","unstructured":"Zuurbier, C. J., Keijzers, P. J., Koeman, A., Van Wezel, H. B. & Hollmann, M. W. Anesthesia\u2019s effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats. Anesth. Analg. 106, 135\u2013142 (2008).","journal-title":"Anesth. Analg."},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus, A., Clement, K. & Sokol, H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70, 1174\u20131182 (2021).","journal-title":"Gut"},{"key":"755_CR39","doi-asserted-by":"publisher","unstructured":"Okahashi, N., Yamada, Y., Iida, J. & Matsuda, F. Isotope calculation gadgets: a series of software for isotope-tracing experiments in garuda platform. Metabolites 12 https:\/\/doi.org\/10.3390\/metabo12070646 (2022).","DOI":"10.3390\/metabo12070646"},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/db10-1740","volume":"60","author":"A Ait-Omar","year":"2011","unstructured":"Ait-Omar, A. et al. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob\/ob and high fat-fed mice. Diabetes 60, 2598\u20132607 (2011).","journal-title":"Diabetes"},{"key":"755_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42531-0","volume":"9","author":"O Horakova","year":"2019","unstructured":"Horakova, O. et al. Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Sci. Rep. 9, 6156 (2019).","journal-title":"Sci. Rep."},{"key":"755_CR42","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1136\/gutjnl-2020-321402","volume":"70","author":"IG Kwon","year":"2021","unstructured":"Kwon, I. G. et al. Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 70, 1847\u20131856 (2021).","journal-title":"Gut"},{"key":"755_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.814074","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu, S. et al. The urinary glucose excretion by sodium-glucose cotransporter 2 inhibitor in patients with different levels of renal function: a systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 12, 814074 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/dc20-2257","volume":"44","author":"NT Mueller","year":"2021","unstructured":"Mueller, N. T. et al. Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial. Diabetes Care 44, 1462\u20131471 (2021).","journal-title":"Diabetes Care"},{"key":"755_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2214\/ajr.104.3.522","volume":"104","author":"SK Kim","year":"1968","unstructured":"Kim, S. K. Small intestine transit time in the normal small bowel study. Am. J. Roentgenol. Radium Ther. Nucl. Med. 104, 522\u2013524 (1968).","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"755_CR46","first-page":"546","volume":"85","author":"JH Bond Jr","year":"1975","unstructured":"Bond, J. H. Jr, Levitt, M. D. & Prentiss, R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J. Lab. Clin. Med. 85, 546\u2013555 (1975).","journal-title":"J. Lab. Clin. Med."},{"key":"755_CR47","first-page":"301","volume":"61","author":"Y Sakar","year":"2010","unstructured":"Sakar, Y. et al. Metformin-induced regulation of the intestinal D-glucose transporters. J. Physiol. Pharmacol. 61, 301\u2013307 (2010).","journal-title":"J. Physiol. Pharmacol."},{"key":"755_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211933120","volume":"120","author":"N Tobar","year":"2023","unstructured":"Tobar, N. et al. Metformin acts in the gut and induces gut-liver crosstalk. Proc. Natl. Acad. Sci. USA. 120, e2211933120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"755_CR49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff, L. et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897\u2013916 (1977).","journal-title":"J. Neurochem."},{"key":"755_CR50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright, E. M., Loo, D. D. & Hirayama, B. A. Biology of human sodium glucose transporters. Physiol. Rev. 91, 733\u2013794 (2011).","journal-title":"Physiol. Rev."},{"key":"755_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81349-7","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci. Rep. 11, 2529 (2021).","journal-title":"Sci. Rep."},{"key":"755_CR52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2337\/diab.17.8.492","volume":"17","author":"A Czyzyk","year":"1968","unstructured":"Czyzyk, A., Tawecki, J., Sadowski, J., Ponikowska, I. & Szczepanik, Z. Effect of biguanides on intestinal absorption of glucose. Diabetes 17, 492\u2013498 (1968).","journal-title":"Diabetes"},{"key":"755_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/dom.12812","volume":"19","author":"T Wu","year":"2017","unstructured":"Wu, T. et al. Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes. Diabetes Obes. Metab. 19, 290\u2013293 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"755_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1113\/jphysiol.2003.049247","volume":"552","author":"F Gouyon","year":"2003","unstructured":"Gouyon, F. et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J. Physiol. 552, 823\u2013832 (2003).","journal-title":"J. Physiol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00755-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:04:55Z","timestamp":1740978295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00755-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: W.O. has received research support and lecture fees from Sumitomo Pharma and Teijin Pharma. K. Sakaguchi and Y. Hirota have received research support from Sumitomo Pharma. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}